Luminex MAP-based services

Rules-Based Medicine (RBM), a Q² Solutions company, has been internally developing and validating assays utilizing the Luminex multi-analyte profile (MAP) technology for more than 20 years. This bead-based platform enables RBM to simultaneously detect and quantify up to 200+ targets in a single sample.

Our comprehensive menu of quantitative, multiplex immunoassays enables you to measure multiple clinically relevant proteins using a small sample volume. Our scientists also developed and validated multiplex, MAP-based profiles for various therapeutic areas.

The RBM MAP technology combines the sensitivity and dynamic range of microsphere-based immuno-multiplexing with the precision and reliability of automated liquid handling to deliver high-quality, cost-effective immunoassay measurements.

For MAP-based services, serum and plasma are the most common sample types, but we can also analyze other biological fluids including cerebrospinal fluid (CSF), urine, tissue culture supernatants, bronchoalveolar lavage, synovial fluid, tissue extracts, tears, and skin washings.

Review our bibliography to see how our assays have supported hundreds of peer-reviewed papers.